Key genetic code change drives common lung cancer type

Cloud technology with futuristic hologram on smartwatch

A team led by researchers at NYU Langone Health’s Perlmutter Cancer Center has identified a gene that drives development of the second most common type of lung carcinoma, offering greater insight into how the disease might be treated.

Video: Expert provides perspective on FDA approval of another experimental Alzheimer’s drug

Previous article

Podcast: Is another US Civil War on the way?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations